Rosales, Thinan L.
HRN: 27-96-46 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
CEFTRIAXONE 1G (VIAL)
10/18/2025
10/25/2025
IV
660MG
OD
PCAP-C
Waiting Final Action
10/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/19/2025
10/26/2025
IV
100mg
Q24
PCAP
Waiting Final Action